Artificial Intelligence Technology Solutions, Inc.: AITX's RAD Opens Q3 With Expanding Orders Across RIO, ROSA and SARA

Artificial Intelligence Technology Solutions, Inc. (AITX) reported new orders for AI-driven security solutions, including RIO 360, RIO Mini, ROSA, and SARA licenses. Orders came from existing customers and partners, expanding deployments and positioning the company for recurring monthly revenue. AITX expects this to build durable revenue streams and grow its presence across multiple sites and industries.

Original reporting
Published Sep 9, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 1:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Artificial Intelligence Technology Solutions, Inc.: AITX's RAD Opens Q3 With Expanding Orders Across RIO, ROSA and SARA — source image
Decision brief

The 30-second read

$AITXBullishLow
01

Why it matters

The announced orders expand the company's recurring revenue base but are modest in scale.

02

Market read

A modest, positive development for AITX; unlikely to drive significant short‑term price movement.

03

What to watch

Potential supply chain or deployment delays could postpone revenue recognition.

Relevance 4/10Novelty 4/10Timing: released today

Background

Artificial Intelligence Technology Solutions (AITX) provides AI‑based security and productivity solutions via its RAD subsidiary.

Company-level read

Ticker impact

$AITXBullishMedium confidence
Context

Press release announcing new orders for RAD's RIO, RIO Mini, ROSA and SARA solutions, expanding recurring monthly revenue.

Expected impact

Modest upside as recurring revenue base expands.

Evidence & confidence

New orders indicate demand traction but scale is limited; impact likely modest on share price.

Market effects

Highlights growing adoption of AI‑driven security solutions in industrial and commercial markets.

Orders span multiple U.S. regions, including Midwest and Alaska, showing geographic diversification.

Limited; company is U.S. focused with no immediate global market shift.

Counterpoint

Order size may be too small to materially affect earnings; investors should wait for larger contract wins.

Key entities

  • Artificial Intelligence Technology Solutions, Inc.

    Issuer of the press release, ticker AITX.

  • Robotic Assistance Devices, Inc.

    RAD unit delivering the new hardware and software solutions.

Related articles

$AITXMed

Artificial Intelligence Technology Solutions Inc. (AITX): Results of Operations and Financial Condition

Artificial Intelligence Technology Solutions Inc. (AITX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Artificial Intelligence Technology Solutions, Inc.: Exhibit 99.1 - Filed by newsfilecorp.com Exhibit 99.1 AITX Reports Q1 FY2027 Results: Total Revenue of $1.83 Million; Revenue Excluding Largest Customer Up 52%; Operating Loss and Cash Use

$AITXMed

Artificial Intelligence Technology Solutions Inc. (AITX): Results of Operations and Financial Condition

Artificial Intelligence Technology Solutions Inc. (AITX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Artificial Intelligence Technology Solutions, Inc.: Exhibit 99.1 - Filed by newsfilecorp.com Exhibit 99.1 AITX Confirms Audited Fiscal Year 2026 Results and Files Form 10-K, Reinforcing Revenue Growth, Gross Margin Expansion, and Its Three-

$LMTMed

New Pentagon Deal Expands Production of Next-Gen Missiles

The Pentagon and Lockheed Martin agreed to expand production of the AIM-260 missile, a next-gen air-to-air weapon. Lockheed Martin claims it offers greater range and effectiveness. The deal includes funding for increased production capacity. Australia also plans to acquire the missile, investing $736 million.

$METAMed

Meta Just Launched a New Subscription Business Built Entirely Around AI. Here's Why It Could Be a Game-Changer.

Meta Platforms (META) launched Meta One, a subscription service offering expanded AI features across Facebook, Instagram, and WhatsApp. Plans range from $7.99 to $499 per month. The move aims to diversify revenue as Meta faces high AI infrastructure costs and relies heavily on advertising. Meta's Q2 revenue rose 28% to $60.8B, but net income fell 15%. Analysts expect Q3 revenue of $73.66B.

$BIIBMedAI 8/10

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-M

Biogen Inc. (BIIB) reported that EMPAVELI (pegcetacoplan) showed a 75% relative reduction in proteinuria in adolescents with C3G or primary IC-MPGN in a Phase 3 study. The FDA recently expanded EMPAVELI's label to include reducing kidney function loss in patients aged 12 and older. The drug is the only approved treatment for these conditions in adolescents, according to the company.